Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Risedronate in Osteoporosis Subjects with Comorbid Diabetes, Hypertension, and/or Dyslipidemia: A Post Hoc Analysis of Phase III Trials Conducted in Japan
Authors
Keywords
Bisphosphonate, Risedronate, Metabolic syndrome, Life style-related disease, Bone mineral density, Bone turnover markers
Journal
CALCIFIED TISSUE INTERNATIONAL
Volume 98, Issue 2, Pages 114-122
Publisher
Springer Nature
Online
2015-10-14
DOI
10.1007/s00223-015-0071-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lifestyle Modification for Metabolic Syndrome: A Systematic Review
- (2014) Nikhil Bassi et al. AMERICAN JOURNAL OF MEDICINE
- Association Between Metabolic Syndrome and Incident Fractures in Korean Men: A 3-Year Follow-Up Observational Study Using National Health Insurance Claims Data
- (2014) Seung Hun Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies
- (2014) S. O'Neill et al. Obesity Reviews
- Biochemical markers of bone turnover in diabetes patients—a meta-analysis, and a methodological study on the effects of glucose on bone markers
- (2014) J. Starup-Linde et al. OSTEOPOROSIS INTERNATIONAL
- The Relationship Among Hypertension, Antihypertensive Medications, and Osteoporosis: A Narrative Review
- (2012) Katarina Ilić et al. CALCIFIED TISSUE INTERNATIONAL
- Bone, sweet bone—osteoporotic fractures in diabetes mellitus
- (2012) Christine Hamann et al. Nature Reviews Endocrinology
- Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
- (2011) Ann V. Schwartz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Metabolic Syndrome—from Insulin Resistance to Obesity and Diabetes
- (2011) Emily Jane Gallagher et al. MEDICAL CLINICS OF NORTH AMERICA
- Bone structure and turnover in type 2 diabetes mellitus
- (2011) A. Shu et al. OSTEOPOROSIS INTERNATIONAL
- Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia
- (2010) Somlak Chuengsamarn et al. BONE
- Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition
- (2010) Keertik Fulzele et al. CELL
- Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism
- (2010) Mathieu Ferron et al. CELL
- Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus
- (2010) Ippei Kanazawa et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes
- (2009) Toru Yamaguchi et al. BONE
- Hypertension Is a Risk Factor for Fractures
- (2008) Peter Vestergaard et al. CALCIFIED TISSUE INTERNATIONAL
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Fracture Risk in Type 2 Diabetes: Update of a Population-Based Study
- (2008) L Joseph Melton et al. JOURNAL OF BONE AND MINERAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started